Premier Graphene Inc (BIEI)

USD 0.0

(0.0%)

Market Cap (In USD)

799.98 Thousand

Revenue (In USD)

-

Net Income (In USD)

-202.17 Thousand

Avg. Volume

9.02 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.0E-4-0.0021
PE
-
EPS
-
Beta Value
-4.689
ISIN
US74048K2033
CUSIP
74048K203
CIK
1515740
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. David Caplan
Employee Count
-
Website
https://www.premierbiomedical.com
Ipo Date
2012-08-15
Details
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.